{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:39:01Z","timestamp":1769171941630,"version":"3.49.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Chidamide (CDM), a novel histone deacetylase inhibitor, is currently used for patients with peripheral T-cell lymphoma. Aspirin (ASA), an anti-inflammatory drug, has been shown to exert anticancer activity. Herein, we investigated the effect of CDM combined with ASA on myelodysplastic syndromes-derived acute myeloid leukemia (AML-MDS) cells and explored the underlying mechanism. The putative targets of CDM and ASA were predicted by network pharmacology approach. GO functional and KEGG pathway enrichment analyses were performed by DAVID. Furthermore, experimental validation was conducted by Cell Counting Kit-8 assay, Flow cytometry and Western blotting. Network pharmacology analysis revealed 36 AML-MDS-related overlapping genes that were targets of CDM and ASA, while 10 hub genes were identified by the plug-in cytoHubba in Cytoscape. Pathway enrichment analysis indicated CDM and ASA significantly affected PI3K\/AKT signaling pathway. Functional experiments demonstrated that the combination of CDM and ASA had a remarkable synergistic anti-proliferative effect by blocking the cell cycle in G0\/G1 phase and inducing apoptosis. Mechanistically, the combination treatment significantly down-regulated the phosphorylation levels of PI3K and AKT. In addition, insulin-like growth factor 1 (IGF-1), an activator of PI3K\/AKT pathway, reversed the effects of the combination treatment. Our findings suggested that CDM combined with ASA exerted a synergetic inhibitory effect on cell growth by inactivating PI3K\/AKT pathway, which might pave the way for effective treatments of AML-MDS.<\/jats:p>","DOI":"10.3389\/fcell.2021.685954","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T06:28:58Z","timestamp":1631168938000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K\/AKT Pathway"],"prefix":"10.3389","volume":"9","author":[{"given":"Simin","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodrigues-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biopha.2016.08.056","article-title":"A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR\/PI3K\/Akt expression.","volume":"84","author":"Banerjee","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia.","volume":"72","author":"Bertacchini","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/bloodadvances.2017008227","article-title":"Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis.","volume":"1","author":"Boddu","year":"2017","journal-title":"Blood Adv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1074\/jbc.RA119.012357","article-title":"Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation.","volume":"295","author":"Braunstein","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1096\/fj.201801931R","article-title":"CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K\/AKT pathway.","volume":"33","author":"Cheng","year":"2019","journal-title":"FASEB J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/1055-9965.epi-18-0366","article-title":"Racial and Ethnic Differences in the Relationship between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.","volume":"27","author":"Erickson","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B9","first-page":"5056","article-title":"Aspirin inhibits the proliferation of synovium-derived mesenchymal stem cells by arresting the cell cycle in the G0\/G1 phase.","volume":"9","author":"Fan","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/ijc.33022","article-title":"Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.","volume":"147","author":"Garc\u00eda Rodr\u00edguez","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-019-2210-0","article-title":"Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20.","volume":"11","author":"Guan","year":"2020","journal-title":"Cell Death Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3324\/haematol.2017.181172","article-title":"Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.","volume":"103","author":"He","year":"2018","journal-title":"Haematologica"},{"key":"B13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3892\/or.2017.5353","article-title":"Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.","volume":"37","author":"He","year":"2017","journal-title":"Oncol. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/1055-9965.epi-18-0965","article-title":"Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.","volume":"28","author":"Hurwitz","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B15","first-page":"3461","article-title":"Chidamide plus decitabine synergistically induces apoptosis of acute myeloid leukemia cells by upregulating PERP.","volume":"12","author":"Li","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2174\/156800961506150805153230","article-title":"A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation.","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"B18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells.","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.biopha.2016.08.023","article-title":"A novel histone deacetylase inhibitor Chidamide induces G0\/G1 arrest and apoptosis in myelodysplastic syndromes.","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/irdr.2016.01024","article-title":"Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China.","volume":"5","author":"Lu","year":"2016","journal-title":"Intractable Rare Dis. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/path.4138","article-title":"Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.","volume":"229","author":"Pennarun","year":"2013","journal-title":"J. Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.3390\/cancers12113334","article-title":"Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.","volume":"12","author":"Ramadan","year":"2020","journal-title":"Cancers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chembiol.2013.10.009","article-title":"Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to BAK\/BAX-dependent apoptosis.","volume":"21","author":"Renault","year":"2014","journal-title":"Chem. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fcell.2020.00146","article-title":"The STRIPAK Complex Regulates Response to Chemotherapy Through p21 and p27.","volume":"8","author":"Rodriguez-Cupello","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100689","DOI":"10.1016\/j.blre.2020.100689","article-title":"Therapeutic strategies in low and high-risk MDS: What does the future have to offer?","volume":"45","author":"Scalzulli","year":"2020","journal-title":"Blood Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.bbmt.2019.03.011","article-title":"Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.","volume":"25","author":"Schroeder","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","article-title":"Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.","volume":"26","author":"Shi","year":"2015","journal-title":"Ann. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4161\/cbt.9.11.11873","article-title":"The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.","volume":"9","author":"Son","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"B29","first-page":"574","article-title":"Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit A.","volume":"9","author":"Sun","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"108793","DOI":"10.1016\/j.cbi.2019.108793","article-title":"Polyphyllin I induces apoptosis and autophagy via modulating JNK and mTOR pathways in human acute myeloid leukemia cells.","volume":"311","author":"Tian","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3892\/mmr.2012.858","article-title":"Antitumor activity of Chidamide in hepatocellular carcinoma cell lines.","volume":"5","author":"Wang","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.phymed.2018.09.218","article-title":"Chidamide-induced ROS accumulation and miR-129-3p-dependent cell cycle arrest in non-small lung cancer cells.","volume":"56","author":"Wu","year":"2019","journal-title":"Phytomedicine"},{"key":"B33","first-page":"7644","article-title":"A combination of low-dose decitabine and chidamide resulted in synergistic effects on the proliferation and apoptosis of human myeloid leukemia cell lines.","volume":"11","author":"Xu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcancer.2019.04.001","article-title":"Emerging role of PI3K\/AKT in tumor-related epigenetic regulation.","volume":"59","author":"Yang","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3389\/fonc.2018.00679","article-title":"Aspirin Inhibits Natural Killer\/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function.","volume":"8","author":"Zhang","year":"2018","journal-title":"Front. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3390\/ijms19072029","article-title":"Aspirin is Involved in the Cell Cycle Arrest, Apoptosis, Cell Migration, and Invasion of Oral Squamous Cell Carcinoma.","volume":"19","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.2147\/ott.s240721","article-title":"The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer.","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.biopha.2018.10.161","article-title":"Puerarin attenuates neurological deficits via Bcl-2\/Bax\/cleaved caspase-3 and Sirt3\/SOD2 apoptotic pathways in subarachnoid hemorrhage mice.","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","article-title":"Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.","volume":"36","author":"Zhou","year":"2018","journal-title":"Invest. New Drugs"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.685954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T06:29:05Z","timestamp":1631168945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.685954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":39,"alternative-id":["10.3389\/fcell.2021.685954"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.685954","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"article-number":"685954"}}